Kelley BG and Thayer SA |
Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15288572
|
Rockwell CE and Kaminski NE |
A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15284281
|
Scorticati C et al. |
The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15280536
|
Akerman S et al. |
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. |
2004 |
Br. J. Pharmacol. |
pmid:15277315
|
Yue HY et al. |
AM404 enhances the spontaneous release of L-glutamate in a manner sensitive to capsazepine in adult rat substantia gelatinosa neurones. |
2004 |
Brain Res. |
pmid:15276889
|
Boldrup L et al. |
A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase. |
2004 |
J. Biochem. Biophys. Methods |
pmid:15262451
|
D'Amico M et al. |
Inhibition by anandamide and synthetic cannabimimetics of the release of [3H]D-aspartate and [3H]GABA from synaptosomes isolated from the rat hippocampus. |
2004 |
Neurochem. Res. |
pmid:15260134
|
Barros DM et al. |
Interactions between anandamide-induced anterograde amnesia and post-training memory modulatory systems. |
2004 |
Brain Res. |
pmid:15234253
|
Lichtman AH et al. |
Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15229230
|
Li J et al. |
Muscle pressor reflex: potential role of vanilloid type 1 receptor and acid-sensing ion channel. |
2004 |
J. Appl. Physiol. |
pmid:15220301
|
Ortega-Gutiérrez S et al. |
Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. |
2004 |
Biochemistry |
pmid:15209515
|
Kraft B et al. |
Cannabinoid receptor-independent suppression of the superoxide generation of human neutrophils (PMN) by CP55 940, but not by anandamide. |
2004 |
Life Sci. |
pmid:15193957
|
MartÃnez-González D et al. |
Oleamide and anandamide effects on food intake and sexual behavior of rats. |
2004 |
Neurosci. Lett. |
pmid:15193744
|
Peroni RN et al. |
Sex-linked differences in the vasorelaxant effects of anandamide in vascular mesenteric beds: role of oestrogens. |
2004 |
Eur. J. Pharmacol. |
pmid:15189776
|
Witting A et al. |
Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. |
2004 |
J. Neurochem. |
pmid:15189359
|
Kim J and Alger BE |
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. |
2004 |
Nat. Neurosci. |
pmid:15184902
|
Alger BE |
Endocannabinoids: getting the message across. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15173576
|
Breivogel CS et al. |
Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids. |
2004 |
Neuropharmacology |
pmid:15165836
|
Chen P et al. |
Metabolism of anandamide in cerebral microvascular endothelial cells. |
2004 |
Prostaglandins Other Lipid Mediat. |
pmid:15165032
|
Russo EB |
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? |
2004 Feb-Apr |
Neuro Endocrinol. Lett. |
pmid:15159679
|
Fride E |
The endocannabinoid-CB receptor system: Importance for development and in pediatric disease. |
2004 Feb-Apr |
Neuro Endocrinol. Lett. |
pmid:15159678
|
Mechoulam R |
The promise of advances in the field of endocannabinoids. |
2004 Feb-Apr |
Neuro Endocrinol. Lett. |
pmid:15159675
|
Karlsson M et al. |
Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments. |
2004 |
Eur J Pharm Sci |
pmid:15158903
|
Mendiguren A and Pineda J |
Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices. |
2004 |
Neurosci. Lett. |
pmid:15157983
|
Lichtman AH et al. |
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. |
2004 |
Pain |
pmid:15157693
|
Koura Y et al. |
Anandamide decreases glomerular filtration rate through predominant vasodilation of efferent arterioles in rat kidneys. |
2004 |
J. Am. Soc. Nephrol. |
pmid:15153559
|
Parkkari T et al. |
Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15149681
|
O'Sullivan SE et al. |
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. |
2004 |
Br. J. Pharmacol. |
pmid:15148250
|
Maccarrone M et al. |
Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex. |
2004 |
J. Neurochem. |
pmid:15147522
|
Fowler CJ et al. |
Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle. |
2004 |
Eur. J. Pharmacol. |
pmid:15145699
|
McQueen DS et al. |
Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats. |
2004 |
Eur. J. Pharmacol. |
pmid:15140635
|
Fegley D et al. |
Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15138300
|
Randall MD et al. |
The complexities of the cardiovascular actions of cannabinoids. |
2004 |
Br. J. Pharmacol. |
pmid:15131000
|
Cernak I et al. |
The "dark side" of endocannabinoids: a neurotoxic role for anandamide. |
2004 |
J. Cereb. Blood Flow Metab. |
pmid:15129189
|
Van Der Stelt M and Di Marzo V |
Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. |
2004 |
Eur. J. Biochem. |
pmid:15128293
|
Pacher P et al. |
Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. |
2004 |
J. Physiol. (Lond.) |
pmid:15121805
|
Kishimoto S et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. |
2004 |
J. Biochem. |
pmid:15115777
|
Centonze D et al. |
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. |
2004 |
Neuropsychopharmacology |
pmid:15100701
|
González S et al. |
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. |
2004 |
Drug Alcohol Depend |
pmid:15099659
|
Valenti M et al. |
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. |
2004 |
Cell. Mol. Life Sci. |
pmid:15095014
|
Fernandez-Espejo E and Galan-Rodriguez B |
Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor. |
2004 |
Psychopharmacology (Berl.) |
pmid:15088080
|
Gardener MJ et al. |
Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. |
2004 |
Br. J. Pharmacol. |
pmid:15066906
|
de Lago E et al. |
Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. |
2004 |
Brain Res. |
pmid:15064146
|
Contassot E et al. |
Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. |
2004 |
Gynecol. Oncol. |
pmid:15047233
|
Szendrei K |
[A novel analgesics made from Cannabis]. |
2004 |
Ideggyogy Sz |
pmid:15042867
|
Joseph J et al. |
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. |
2004 |
Cancer Immunol. Immunother. |
pmid:15034673
|
Oliver D et al. |
Functional conversion between A-type and delayed rectifier K+ channels by membrane lipids. |
2004 |
Science |
pmid:15031437
|
Evans RM et al. |
Multiple actions of anandamide on neonatal rat cultured sensory neurones. |
2004 |
Br. J. Pharmacol. |
pmid:15023857
|
Cruz F |
Mechanisms involved in new therapies for overactive bladder. |
2004 |
Urology |
pmid:15013655
|
Fernandez-Espejo E et al. |
Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function. |
2004 |
Neuropsychopharmacology |
pmid:15010694
|
Berger C et al. |
Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? |
2004 |
J. Neurochem. |
pmid:15009671
|
Price TJ et al. |
Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. |
2004 |
Br. J. Pharmacol. |
pmid:15006899
|
Sun YX et al. |
Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. |
2004 |
Biochem. J. |
pmid:14998370
|
Steffens M et al. |
Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. |
2004 |
Br. J. Pharmacol. |
pmid:14993102
|
Costanzi M et al. |
Effects of anandamide and morphine combinations on memory consolidation in cd1 mice: involvement of dopaminergic mechanisms. |
2004 |
Neurobiol Learn Mem |
pmid:14990234
|
Fernández-Solari J et al. |
Alcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid system. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:14981261
|
Basta PV et al. |
Preparation of monoclonal antibodies reactive to the endogenous small molecule, anandamide. |
2004 |
J. Immunol. Methods |
pmid:14980433
|
Guo J and Ikeda SR |
Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. |
2004 |
Mol. Pharmacol. |
pmid:14978245
|
Ligresti A et al. |
Further evidence for the existence of a specific process for the membrane transport of anandamide. |
2004 |
Biochem. J. |
pmid:14969584
|
Lin GC et al. |
Gap junctional communication modulates agonist-induced calcium oscillations in transfected HeLa cells. |
2004 |
J. Cell. Sci. |
pmid:14762115
|
Matias I et al. |
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:14757851
|
Moezi L et al. |
Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide. |
2004 |
Eur. J. Pharmacol. |
pmid:14751408
|
Dennedy MC et al. |
Cannabinoids and the human uterus during pregnancy. |
2004 |
Am. J. Obstet. Gynecol. |
pmid:14749627
|
Murillo-Rodriguez E et al. |
Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. |
2003 |
Sleep |
pmid:14746372
|
de Lago E et al. |
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. |
2004 |
Eur. J. Pharmacol. |
pmid:14744610
|
Weber A et al. |
Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. |
2004 |
J. Lipid Res. |
pmid:14729864
|
Maccarrone M |
Inhibition of anandamide hydrolysis: cells also know how to do it. |
2004 |
Trends Mol Med |
pmid:14720580
|
Akerman S et al. |
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:14718591
|
Ruiz-Llorente L et al. |
Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study. |
2004 |
Br. J. Pharmacol. |
pmid:14718261
|
Lees G and Dougalis A |
Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro. |
2004 |
Brain Res. |
pmid:14715144
|
Devane WA et al. |
Isolation and structure of a brain constituent that binds to the cannabinoid receptor. |
1992 |
Science |
pmid:1470919
|
Piomelli D |
THC: moderation during implantation. |
2004 |
Nat. Med. |
pmid:14702623
|
Kasai HF et al. |
Analyses of anandamide and endocannabinoid-like compounds using collision-induced dissociation in fast atom bombardment ionization-mass spectrometry and gas chromatography/chemical ionization-mass spectrometry. |
2003 |
Anal Sci |
pmid:14696920
|
Wenger T et al. |
The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice. |
2003 |
Neuroendocrinology |
pmid:14688442
|
Motobe T et al. |
Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome. |
2004 |
Shock |
pmid:14676677
|
Arizzi MN et al. |
Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide. |
2004 |
Life Sci. |
pmid:14672756
|
Nilsson O et al. |
Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures. |
2003 |
Comp. Biochem. Physiol. C Toxicol. Pharmacol. |
pmid:14659458
|
Wang H et al. |
Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. |
2003 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:14645706
|
Zoratti C et al. |
Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells. |
2003 |
Br. J. Pharmacol. |
pmid:14645143
|
Jones S and Howl J |
Cannabinoid receptor systems: therapeutic targets for tumour intervention. |
2003 |
Expert Opin. Ther. Targets |
pmid:14640910
|
Farquhar-Smith WP and Rice AS |
A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia. |
2003 |
Anesthesiology |
pmid:14639155
|
Kollarik M and Undem BJ |
Activation of bronchopulmonary vagal afferent nerves with bradykinin, acid and vanilloid receptor agonists in wild-type and TRPV1-/- mice. |
2004 |
J. Physiol. (Lond.) |
pmid:14634201
|
Okamoto Y et al. |
Molecular characterization of a phospholipase D generating anandamide and its congeners. |
2004 |
J. Biol. Chem. |
pmid:14634025
|
Sparling PB et al. |
Exercise activates the endocannabinoid system. |
2003 |
Neuroreport |
pmid:14625449
|
Seagard JL et al. |
Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition. |
2004 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:14615281
|
McAllister SD et al. |
An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region. |
2003 |
J. Med. Chem. |
pmid:14613317
|
Gaetani S et al. |
Anandamide hydrolysis: a new target for anti-anxiety drugs? |
2003 |
Trends Mol Med |
pmid:14604824
|
Egashira N et al. |
Anandamide inhibits the DOI-induced head-twitch response in mice. |
2004 |
Psychopharmacology (Berl.) |
pmid:14586538
|
Biswas KK et al. |
Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis. |
2003 |
Hepatology |
pmid:14578855
|
Johnson RP et al. |
System-specific O2 sensitivity of the tandem pore domain K+ channel TASK-1. |
2004 |
Am. J. Physiol., Cell Physiol. |
pmid:14576090
|
Chen N et al. |
Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. |
2003 |
Eur. J. Pharmacol. |
pmid:14575792
|
Han B et al. |
Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. |
2003 |
J. Nat. Prod. |
pmid:14575438
|
Steffens M et al. |
Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex. |
2003 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:14566450
|
Maccarrone M et al. |
Endocannabinoid degradation, endotoxic shock and inflammation. |
2002 |
Curr Drug Targets Inflamm Allergy |
pmid:14561206
|
Gurney AM et al. |
Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. |
2003 |
Circ. Res. |
pmid:14551239
|
Marsicano G et al. |
CB1 cannabinoid receptors and on-demand defense against excitotoxicity. |
2003 |
Science |
pmid:14526074
|
Mechoulam R and Lichtman AH |
Neuroscience. Stout guards of the central nervous system. |
2003 |
Science |
pmid:14526067
|
Vandevoorde S et al. |
Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase. |
2003 |
J. Med. Chem. |
pmid:14521402
|
Ross RA |
Anandamide and vanilloid TRPV1 receptors. |
2003 |
Br. J. Pharmacol. |
pmid:14517174
|
Fowler CJ et al. |
Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin. |
2003 |
J Enzyme Inhib Med Chem |
pmid:14506913
|